title: The highly pathogenic H7N3 avian influenza strain from July 2012 in Mexico acquired an extended cleavage site through recombination with host 28S rRNA.
abstract: BACKGROUND
  A characteristic difference between highly and non-highly pathogenic avian influenza strains is the presence of an extended, often multibasic, cleavage motif insertion in the hemagglutinin protein. Such motif is found in H7N3 strains from chicken farm outbreaks in 2012 in Mexico.
  
  
  METHODS
  Through phylogenetic, sequence and structural analysis, we try to shed light on the role, prevalence, likelihood of appearance and origin of the inserted cleavage motifs in these H7N3 avian influenza strains.
  
  
  RESULTS
  The H7N3 avian influenza strain which caused outbreaks in chicken farms in June/July 2012 in Mexico has a new extended cleavage site which is the likely reason for its high pathogenicity in these birds. This cleavage site appears to have been naturally acquired and was not present in the closest low pathogenic precursors. Structural modeling shows that insertion of a productive cleavage site is quite flexible to accept insertions of different length and with sequences from different possible origins. Different from recent cleavage site insertions, the origin of the insert here is not from the viral genome but from host 28S ribosomal RNA (rRNA) instead. This is a novelty for a natural acquisition as a similar insertion has so far only been observed in a laboratory strain before. Given the abundance of viral and host RNA in infected cells, the acquisition of a pathogenicity-enhancing extended cleavage site through a similar route by other low-pathogenic avian strains in future does not seem unlikely. Important for surveillance of these H7N3 strains, the structural sites known to enhance mammalian airborne transmission are dominated by the characteristic avian residues and the risk of human to human transmission should currently be low but should be monitored for future changes accordingly.
  
  
  CONCLUSIONS
  This highly pathogenic H7N3 avian influenza strain acquired a novel extended cleavage site which likely originated from recombination with 28S rRNA from the avian host. Notably, this new virus can infect humans but currently lacks critical host receptor adaptations that would facilitate human to human transmission.
authors: Bioinformatics Institute (BII), Agency for Science, Technology and Research (A STAR), Singapore. sebastianms@bii.a-star.edu.sg
authors: Sebastian
authors: S
authors: Maurer-Stroh
authors: Raphael T C
authors: RT
authors: Lee
authors: Vithiagaran
authors: V
authors: Gunalan
authors: Frank
authors: F
authors: Eisenhaber
mesh_terms: D000818:Animals; D002645:Chickens; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000235:genetics*; D057920:Influenza A Virus, H7N3 Subtype / Q000235:genetics* / Q000302:isolation & purification*; D005585:Influenza in Birds / Q000821:virology*; D008800:Mexico; D010802:Phylogeny; D012339:RNA, Ribosomal, 28S / Q000235:genetics*; D012367:RNA, Viral / Q000235:genetics*; D011995:Recombination, Genetic; D017422:Sequence Analysis, DNA
chemical_list: D019267:Hemagglutinin Glycoproteins, Influenza Virus; D012339:RNA, Ribosomal, 28S; D012367:RNA, Viral
references: Virology. 1995 Jun 1;209(2):664-70
references: 7778300
references: Proteins. 2009;77 Suppl 9:114-22
references: 19768677
references: Virol J. 2011 Jun 28;8:328
references: 21711553
references: Protein Eng Des Sel. 2004 Jan;17(1):107-12
references: 14985543
references: PLoS Pathog. 2010 Sep 02;6(9):e1001081
references: 20824086
references: Cell. 1998 Oct 30;95(3):409-17
references: 9814710
references: Emerg Infect Dis. 2004 Apr;10(4):693-9
references: 15200862
references: Biochem J. 1997 Nov 1;327 ( Pt 3):625-35
references: 9599222
references: Science. 2012 Jun 22;336(6088):1534-41
references: 22723413
references: Rev Med Virol. 2001 Jul-Aug;11(4):227-41
references: 11479929
references: Science. 2012 Jun 22;336(6088):1541-7
references: 22723414
references: J Gen Virol. 2005 Mar;86(Pt 3):727-731
references: 15722533
references: Mol Immunol. 2011 Mar;48(6-7):924-30
references: 21256597
references: Nature. 1989 Jul 13;340(6229):156-7
references: 2544809
references: Syst Biol. 2010 May;59(3):307-21
references: 20525638
references: Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2579-84
references: 22308331
references: Virology. 1994 Aug 1;202(2):988-91
references: 8030261
references: Poult Sci. 1998 Dec;77(12):1748-54
references: 9872573
references: MMWR Morb Mortal Wkly Rep. 2012 Sep 14;61(36):726-7
references: 22971746
references: J Hered. 1994 May-Jun;85(3):211-7
references: 8014461
references: Mol Biol Evol. 2011 Oct;28(10):2731-9
references: 21546353
references: Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 2):S16-9
references: 7551406
references: J Virol. 2010 Aug;84(16):7953-60
references: 20519405
references: J Virol. 2012 Aug;86(16):8645-52
references: 22674977
references: Nature. 2012 May 02;486(7403):420-8
references: 22722205
references: Rev Med Virol. 2010 Sep;20(5):298-310
references: 20629046
references: J Virol. 2012 Apr;86(8):4370-9
references: 22345462
references: J Gen Virol. 1996 Jul;77 ( Pt 7):1493-504
references: 8757992
references: Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
references: 9254694
references: J Virol. 2012 Mar;86(5):2706-14
references: 22205751
references: Nucleic Acids Res. 2011 Jan;39(Database issue):D38-51
references: 21097890
references: J Gen Virol. 2011 Jun;92(Pt 6):1410-1415
references: 21346026
references: Cell Cycle. 2010 Sep 15;9(18):3826-8
references: 20930526
references: Nat Struct Biol. 2003 Jul;10(7):520-6
references: 12794637
references: Brief Bioinform. 2008 Jul;9(4):286-98
references: 18372315
references: J Virol. 2012 Apr;86(7):3975-84
references: 22278228
references: Virology. 1995 Oct 20;213(1):223-30
references: 7483266
references: Virology. 1994 Oct;204(1):462-5
references: 8091680